IFI-A · Gallic Acid Enhancement

Specimen SS-F-AST-278 // ASTRINGENCY · IFI-A

Gallic Acid Enhancement V-PR-B

Punica granatum

Pomegranate

Tier VGallic Acid Enhancement

Target Trait

4.37×

fold-change

Gallic acid (hydrolysable tannin precursor) accumulation

Technical Specifications

SKU

SS-F-AST-278

Genomic Edits

9

GC Content

46.9%

Construct Length

4,701 bp

Promoter System

Ubiquitin / T7

Expression System

Protoplast PEG-fusion

Host Strain

PEG-mediated

Receptor Target

Polyphenol-astringency axis

IFI Score

437

Pathway Edits

  • GAE upregulation (gallate-ester hydrolase) for galloyl group liberation
  • GT1 galloylquinic acid glucosyltransferase amplification
  • BAHD-GalT acyltransferase overexpression for galloyl-glucose ester formation
  • 4CL (4-coumarate:CoA ligase) shikimate branch redirection
  • C4H (cinnamate 4-hydroxylase) phenylpropanoid flux enhancement
  • Protoplast PEG-fusion transient and stable integration protocol
  • Enhanced flux via 5'UTR synthetic leader sequence optimization

Key Interventions

Shikimate pathway carbon flux redirection toward gallic acid branchGalloyl-glucose ester accumulation for hydrolysable tannin precursor poolPolyphenol galloylation capacity expansion in Punica granatumPEG-4000 mediated membrane fusion at 37°CVariant B enhanced: iterative codon optimization for host-matched expression

IFI Subscale Profile

IFI Profile

IFI-S
—
IFI-U
—
IFI-B
—
IFI-K
—
IFI-C
—
IFI-P
—
IFI-A
437
IFI-F
—

Use Case

Flagship pharmaceutical-grade ellagic acid production, premium nutraceutical pomegranate ingredient manufacturing, precision hydrolysable tannin standardization. Enhanced variant for premium or research-grade applications requiring peak astringency fidelity.

License

$10049 · Tier V License

Includes full construct sequence, CRISPR guide designs, pathway edit specifications, flux balance analysis, and IFI validation data.

Already purchased?

Back to Astringency · IFI-AAll Modalities